This study is in progress, not accepting new patients
Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection
Summary
- Eligibility
- for people ages 3 months to 18 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Ngoc Ly
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Ngoc Ly
My research has focused on the influences of heredity, as well as prenatal and infant environmental exposures ( including environmental, microbial, and nutritional influences) on immune responses and clinical symptoms of allergy and asthma.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- ID
- NCT03219164
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated